Cargando…
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
BACKGROUND: The DACT (Dishevelled-associated antagonist of β-catenin) family of scaffold proteins may play important roles in tumorigenesis. However, the epigenetic changes of DACT1, 2, 3 and their effect on esophageal squamous cell carcinoma (ESCC) have not been investigated so far. The aim of this...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225534/ https://www.ncbi.nlm.nih.gov/pubmed/28077137 http://dx.doi.org/10.1186/s12929-016-0308-6 |
_version_ | 1782493525959507968 |
---|---|
author | Guo, Yan-li Shan, Bao-En Guo, Wei Dong, Zhi-Ming Zhou, Zhen Shen, Su-Peng Guo, Xin Liang, Jia Kuang, Gang |
author_facet | Guo, Yan-li Shan, Bao-En Guo, Wei Dong, Zhi-Ming Zhou, Zhen Shen, Su-Peng Guo, Xin Liang, Jia Kuang, Gang |
author_sort | Guo, Yan-li |
collection | PubMed |
description | BACKGROUND: The DACT (Dishevelled-associated antagonist of β-catenin) family of scaffold proteins may play important roles in tumorigenesis. However, the epigenetic changes of DACT1, 2, 3 and their effect on esophageal squamous cell carcinoma (ESCC) have not been investigated so far. The aim of this study was to investigate the promoter methylation and expression of DACT family, in order to elucidate more information on the role of DACT with regard to the progression and prognosis of ESCC. METHODS: MSP and BGS methods were respectively applied to examine the methylation status of DACT; RT-PCR, Western blot and immunohistochemistry methods were respectively used to determine the mRNA and protein expression of DACT; MTT, Colony-formation and Wound-healing assay were performed to assess the effect of DACT1 and DACT2 on proliferation and migration of esophageal cancer cells. RESULTS: Frequent reduced expression of DACT1, DACT2 and DACT3 were found in esophageal cancer cell lines and the expression levels of DACT1 and DACT2 were reversed by 5-Aza-Dc. Decreased mRNA and protein expression of DACT1 and DACT2 were observed in ESCC tumor tissues and were associated with the methylation status of transcription start site (TSS) region. The hypermethylation of CpG islands (CGI) shore region in DACT1 was observed both in tumor and corresponding adjacent tissues but wasn’t related to the transcriptional inhibition of DACT1. The methylation status of TSS region in DACT1 and DACT2 and the protein expression of DACT2 were independently associated with ESCC patients’ prognosis. CONCLUSIONS: The TSS region hypermethylation may be one of the main mechanisms for reduced expression of DACT1 and DACT2 in ESCC. The simultaneous methylation of DACT1 and DACT2 may play important roles in progression of ESCC and may serve as prognostic methylation biomarkers for ESCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12929-016-0308-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5225534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52255342017-01-17 Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma Guo, Yan-li Shan, Bao-En Guo, Wei Dong, Zhi-Ming Zhou, Zhen Shen, Su-Peng Guo, Xin Liang, Jia Kuang, Gang J Biomed Sci Research BACKGROUND: The DACT (Dishevelled-associated antagonist of β-catenin) family of scaffold proteins may play important roles in tumorigenesis. However, the epigenetic changes of DACT1, 2, 3 and their effect on esophageal squamous cell carcinoma (ESCC) have not been investigated so far. The aim of this study was to investigate the promoter methylation and expression of DACT family, in order to elucidate more information on the role of DACT with regard to the progression and prognosis of ESCC. METHODS: MSP and BGS methods were respectively applied to examine the methylation status of DACT; RT-PCR, Western blot and immunohistochemistry methods were respectively used to determine the mRNA and protein expression of DACT; MTT, Colony-formation and Wound-healing assay were performed to assess the effect of DACT1 and DACT2 on proliferation and migration of esophageal cancer cells. RESULTS: Frequent reduced expression of DACT1, DACT2 and DACT3 were found in esophageal cancer cell lines and the expression levels of DACT1 and DACT2 were reversed by 5-Aza-Dc. Decreased mRNA and protein expression of DACT1 and DACT2 were observed in ESCC tumor tissues and were associated with the methylation status of transcription start site (TSS) region. The hypermethylation of CpG islands (CGI) shore region in DACT1 was observed both in tumor and corresponding adjacent tissues but wasn’t related to the transcriptional inhibition of DACT1. The methylation status of TSS region in DACT1 and DACT2 and the protein expression of DACT2 were independently associated with ESCC patients’ prognosis. CONCLUSIONS: The TSS region hypermethylation may be one of the main mechanisms for reduced expression of DACT1 and DACT2 in ESCC. The simultaneous methylation of DACT1 and DACT2 may play important roles in progression of ESCC and may serve as prognostic methylation biomarkers for ESCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12929-016-0308-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-11 /pmc/articles/PMC5225534/ /pubmed/28077137 http://dx.doi.org/10.1186/s12929-016-0308-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Guo, Yan-li Shan, Bao-En Guo, Wei Dong, Zhi-Ming Zhou, Zhen Shen, Su-Peng Guo, Xin Liang, Jia Kuang, Gang Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
title | Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
title_full | Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
title_fullStr | Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
title_full_unstemmed | Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
title_short | Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
title_sort | aberrant methylation of dact1 and dact2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225534/ https://www.ncbi.nlm.nih.gov/pubmed/28077137 http://dx.doi.org/10.1186/s12929-016-0308-6 |
work_keys_str_mv | AT guoyanli aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT shanbaoen aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT guowei aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT dongzhiming aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT zhouzhen aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT shensupeng aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT guoxin aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT liangjia aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma AT kuanggang aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma |